Effects of AntiMycobacterium Tuberculosis Nanoherbal Legundy Leaf Extract (Vitex trifolia)
DOI:
https://doi.org/10.18196/mmjkk.v21i1.6497Keywords:
Vitex trifolia leaf extract, antibacterial, Mycobacterium tuberculosisAbstract
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Indonesia ranks 2nd largest in the world after India. Resistance to anti-tuberculosis drugs is one of the difficulties in treating tuberculosis. This research aim to determine the effectiveness of legundi (Vitex trifolia) leaf extract nanoherbal in killing Mycobacterium tuberculosis. This study was conducted with an experimental design using M. tuberculosis colonies taken from 25 samples of aspirate of tuberculosis patients with lymph nodes and then given the ethanol extract of legundi leaves (70% and 90%) with the process of making nanoparticle extracts. The evaluation of the observations was in the form of measuring the inhibition zone for bacterial growth which were categorized as weak (<5mm), moderate (6-10mm), strong (11-20 mm) and very strong (> 21mm). The results of the study from 6 repetitions found that the inhibition zone category was 0% weak, 39% moderate, strong 52.3%, and very strong 8.7%. Comparison of the concentration of legundi leaf extract to the diameter of the bacterial growth inhibitory zone was analyzed using the Kruskal Wallis test, which found a significant relationship with p value = 0.000 (<0.05). Legundi's leaf extract can be used as an antibacterial agent for M. tuberculosis.
References
Banuls AL, Sonou A, Van Anh NT, Godreuil S. Mycobacterium tuberculosis : ecology and evolution of a human bacterium. J Med Microbiol. 2015 Nov; 64 (11): p. 1261-1269.
Dinas Kesehatan Provinsi Sumatera Utara. Profil Kesehatan Kota Medan. Medan: 2016 [cited 2020 Mar 10]. Available from: Profil Kes Prov Sumut 2016 eBooks.
Yunita SI, Kusmiati T. TB MDR Primer dengan Limfadenitis TB pada Wanita SLE. J Respirasi: 2015 Sep; 1 (3): p. 81-87.
Kemenkes RI. Profil Kesehatan Indonesia 2017. Indonesia : 2018. [cited 2020 Mar 10]
Flynn JL, Chan J. Immunology of Tuberculosis. Annual Review of Immunology. 2001 Apr;19 (1); p. 93–129.
Perhimpunan Dokter Paru Indonesia. Tuberkulosis Pedoman Diagnosis dan Penatalaksanaan di Indonesia. Jakarta: [cited 2020 Mar 20] PDPI; 2006.
Mustanir dan Rosnani. Isolasi Senyawa Bioaktif Penolak (Repellent) Nyamuk dari Ekstrak Aseton Batang Tumbuhan Legundi (Vitex trifolia). Buletin Littro. 2008 ;19 (2): p. 174-180
Listiawati Y. Uji Efek Antipiretik Ekstrak Etanol Daun Legundi (Vitex trifolia Linn) pada Kelinci yang Diinduksi Vaksin Dpt-Hb. Universitas Muhammadiyah Surakarta. 2010 [cited 2011 Jan 31]. Available from : http://eprints.ums.ac.id/10093
Tiwari N, Thakur J, Saikia D, Gupta MM. Antitubercular diterpenoids from Vitex trifolia. Phytomedicine. 2013 May 15;20(7):605-10.
Lubis HML, Hariaji I. Ekstrak Buah Legundi (Vitex trifolia) Mampu Menghambat Pembelahan dan Pertumbuhan Sel Tumor Kulit Tikus. Mutiara Medika Jurnal Kedokteran dan Kesehatan. 2017 Jan 17 (1): p. 1-6.
Jawetz, Melnick, Adelberg. Mikrobiologi Kedokteran. 27th ed. Jakarta: EGC; 2016
Anggraini A, Yuniningsih S, Sota MM. Pengaruh Ph Terhadap Kualitas Produk Etanol dari Molasses melalui Proses Fermentasi. Jurnal Reka Buana. 2017; 2 (2): p. 99-105.
Mahardika HA, Sarwiyono, Surjowardojo P. Ekstrak Metanol Daun Kersen (Muntingia calabura L) sebagai Antimikroba Alami terhadap Bakteri Staphylococcus aureus Penyebab Mastitis Subklinis pada Sapi Perah. Jurnal Ternak Tropika. 2014;15 (2): p. 15-22.
Geetha V, Doss A, Doss AP. Antimicrobial Potential of Vitex trifolia Linn. Anc Sci Life. 2004 Apr; 23 (4): 30-2
Amanda EA, Oktiani BW, Panjaitan FUA. Efektivitas Antibakteri Ekstrak Flavonoid Propolis Trigona Sp (Trigona thorasica) terhadap Pertumbuhan Bakteri Porphyromonas gingivalis. Jurnal Kedokteran Gigi. 2019; 3 (1): p. 23-28.
Downloads
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.